The antioxidant paradox: Less paradoxical now?

British Journal of Clinical Pharmacology

Volumn 75, Issue 3, 2013, Pages 637-644

  Halliwell, Barry ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antioxidants; Free radicals; Oxidative damage; Oxidative stress; Redox

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; CAROTENOID; COPPER; GLUTATHIONE; HYDROGEN PEROXIDE; IRON; ISOPROSTANE DERIVATIVE; OXYGEN RADICAL; POLYPHENOL; REACTIVE OXYGEN METABOLITE; TOCOPHEROL;

ANTIOXIDANT ACTIVITY; ARTICLE; GASTROINTESTINAL TRACT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; NONHUMAN; NUTRITION; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; THERAPY EFFECT;

ANIMALS; ANTIOXIDANTS; DIET; DIETARY SUPPLEMENTS; FREE RADICALS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84868107243     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04272.x     Document Type: Article

References (115)

1. Finley JW, Kong AN, Hintze KJ, Jeffrey EH, Ji LL, Lei XG. Antioxidants in foods: state of the science important to the food industry. J Agric Food Chem 2011; 59: 6837-46.
2. Alin J, Hakkarainen M. Microwave heating causes rapid degradation of antioxidants in polypropylene packaging, leading to greatly increased specific migration to food stimulants as shown by ESI-MS and GC-MS. J Agric Food Chem 2011; 59: 5418-27.
3. Gutteridge JMC, Halliwell B. Antioxidants: molecules, medicines and myths. Biochem Biophys Res Commun 2010; 393: 561-4.
4. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012 (in press).
5. Halliwell B. Free Radicals in Biology and Medicine, 4th edn. Oxford: Oxford University Press, 2007.
6. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008; 295: C849-68.
7. Sies H. Biological redox systems and oxidative stress. Cell Mol Life Sci 2007; 64: 2181-8.
8. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans 2007; 35: 1147-9.
9. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and cell culture. How should you do it and what does it mean? Br J Pharmacol 2004; 141: 231-55.
10. Murphy MP, Holmgren A, Larsson NG, Halliwell B, Chang CJ, Kalyanaraman B, Rhee SG, Thornalley PJ, Partridge L, Gems D, Nyström T, Belousov V, Schumacker PT, Winterbourn CC. Unraveling the biological roles of reactive oxygen species. Cell Metab 2011; 13: 361-6.
11. Dickinson BC, Chang CJ. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol 2011; 7: 504-11.
12. Halliwell B. How to characterize an antioxidant: an update. Biochem Soc Symp 2005; 61: 73-101.
13. Niki E. Assessment of antioxidant capacity in vitro and in vivo. Free Radic Biol Med 2010; 49: 503-15.
14. Prior RL, Wu X, Schaich K. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem 2005; 53: 4290-302.
15. Halliwell B, Rafter J, Jenner A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr 2005; 81: 268S-76S.
16. Møller P, Loft S. Oxidative DNA damage in human white blood cells in dietary antioxidant intervention studies. Am J Clin Nutr 2002; 76: 303-10.
17. Halliwell B. Oxidative stress in cell culture: an under-appreciated problem. FEBS Lett 2003; 540: 3-6.
18. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 2008; 476: 107-12.
19. Long LH, Hoi A, Halliwell B. Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media. Arch Biochem Biophys 2010; 501: 162-9.
20. Schaffer S, Halliwell B. Comment on hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J Agric Food Chem 2011; 59: 10770-1.
21. Kasper JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009; 47: 1304-9.
22. Mattson MP, Cheng A. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 2006; 29: 632-9.
23. Gruber J, Ng LF, Poovathingal S, Halliwell B. Deceptively simple but simply deceptive -Caenorhabditis elegans lifespan studies: considerations for ageing and antioxidant effects. FEBS Lett 2009; 583: 3377-87.
24. Gruber J, Ng LF, Fong S, Wong YT, Koh SA, Chen CB, Shui G, Cheong WF, Schaffer S, Wenk MR, Halliwell B. Mitochondrial changes in ageing Caenorhabditis elegans - what do we learn from superoxide dismutase knockouts? PLoS ONE 2011; 6: e19444.
25. Pun PB, Gruber J, Tang SY, Schaffer S, Ong RL, Fong S, Ng LF, Cheah I, Halliwell B. Ageing in nematodes: do antioxidants extend lifespan in Caenorhabditis elegans? Biogerontology 2010; 11: 17-30.
26. Gruber J, Schaffer S, Halliwell B. The mitochondrial free radical theory of ageing - where do we stand? Front Biosci 2008; 13: 6554-79.
27. Gems D, Doonan R. Antioxidant defense and aging in C.elegans: is the oxidative damage theory of aging wrong? Cell Cycle 2009; 8: 1681-7.
28. Hekimi S, Lapointe J, Wen Y. Taking a 'good' look at free radicals in the aging process. Trends Cell Biol 2011; 21: 569-76.
29. Porter WL. Paradoxical behavior of antioxidants in food and biological systems. Toxicol Ind Health 1993; 9: 93-122.
30. Akagawa M, Shigemitsu T, Suyama K. Production of hydrogen peroxide by polyphenols and polyphenol-rich beverages under quasi-physiological conditions. Biosci Biotechnol Biochem 2003; 67: 2632-40.
31. Zhou L, Elias RJ. Investigating the hydrogen peroxide quenching capacity of proteins in polyphenol-rich foods. J Agric Food Chem 2011; 59: 8915-22.
32. Halliwell B. The antioxidant paradox. Lancet 2000; 355: 1179-80.
33. McNaught K St P, Olanow CW, Halliwell B, Isacson O, Jenner P. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci 2001; 2: 589-94.
34. Mason PA, Cox LS. The role of DNA exonucleases in protecting genome stability and their impact on ageing. Age. DOI: 10.1007/s11357-011-9306-5.
35. Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, Davies KJ. The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 2010; 432: 585-94.
36. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 2009; 46: 531-42.
37. Cadet J, Douki T, Ravanat JL. Measurement of oxidatively generated base damage in cellular DNA. Mutat Res 2011; 711: 3-12.
38. 2-isoprostanes in inflammation and oxidative stress related pathology. Mol Cells 2010; 30: 383-91.
39. Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurements. Free Radic Biol Med 2002; 32: 1102-15.
40. Broedbaek K, Weimann A, Stovgaard ES, Poulsen HE. Urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes. Free Radic Biol Med 2011; 51: 1473-9.
41. Giustarini D, Dalle-Donne I, Tsikas D, Rossi R. Oxidative stress and human disease: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 2009; 46: 241-81.
42. 2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med 2011; 50: 559-66.
43. Praticò D. The neurobiology of isoprostanes and Alzheimer's disease. Biochim Biophys Acta 2010; 1801: 930-3.
44. Halliwell B. Free radicals and antioxidants -quo vadis? Trends Pharmacol Sci 2011; 32: 125-30.
45. 2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 639-44.
46. Fraley AE, Schwartz GC, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, for the MIRACL Study Investigators. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes. J Am Coll Cardiol 2009; 53: 2186-96.
47. 2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared. Rapid Commun Mass Spectrom 2011; 25: 463-8.
48. 2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 2009; 47: 1101-7.
49. Cooke MS. A commentary on 'urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG'. What is ELISA detecting? Free Radic Biol Med 2009; 47: 30-1.
50. Garratt LW, Mistry V, Singh R, Sandh JK, Sheil B, Cooke MS, Sly PE, on behalf of ARESTCF. Interpretation of urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine is adversely affected by methodological inaccuracies when using a commercial ELISA. Free Radic Biol Med 2010; 48: 1460-4.
51. 2-isoprostanes as markers of in vivo lipid peroxidation: a comparison of enzyme immunoassays with gas chromatography-mass spectrometry in domestic animal species. J Vet Diagn Invest 2010; 22: 200-9.
52. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280: 1-8.
53. Niethammer P, Grabher C, Look AT, Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates wound detection in zebrafish. Nature 2009; 459: 996-9.
54. 2O, and protein chaperones. Antioxid Redox Signal 2011; 15: 781-94.
55. Jiang F, Zhang Y, Dusting GJ. NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev 2011; 63: 18-242.
56. 2 accumulation for cell signaling. Cell 2010; 140: 517-28.
57. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8: 813-24.
58. Halliwell B, Cross CE, Gutteridge JMC. Free radicals, antioxidants, and human disease. Where are we now? J Lab Clin Med 1992; 119: 598-620.
59. Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010; 38: 96-109.
60. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007; 401: 1-11.
61. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach. Nat Rev Drug Discov 2009; 8: 579-91.
62. Clark TA, Lee HP, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Casadesus G, Smith MA, Lee HG, Perry G. Oxidative stress and its implications for future treatments and management of Alzheimer disease. Int J Biomed Sci 2010; 6: 225-7.
63. Halliwell B. Oxidative stress and neurodegeneration; where are we now? J Neurochem 2006; 97: 1634-58.
64. Aluise CD, Robinson RA, Cai J, Pierce WM, Markesbery WR, Butterfield DA. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. J Alzheimers Dis 2011; 23: 257-69.
65. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-25.
66. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-478.
67. Sareila O, Kelkka T, Pizzolla A, Hultqvist M, Holmdahl R. NOX2 complex-derived ROS as immune regulators. Antioxid Redox Signal 2011; 15: 2197-208.
68. Lee K, Won HY, Bae MA, Hong J, Hwang ES. Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proc Natl Acad Sci U S A 2011; 108: 9548-53.
69. Meissner F, Seger RA, Moshous D, Fischer A, Reichenback J, Zychlinsky A. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 2010; 116: 1570-3.
70. Halliwell B. Phagocyte-derived reactive species: salvation or suicide? Trends Biochem Sci 2006; 31: 509-15.
71. Schaffer S, Halliwell B. Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes Nutr 2012. DOI: 10.1007/s12263-011-0255-5.
72. Goodman M, Bostick RM, Kucuk O, Jones DP. Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic Biol Med 2011; 51: 1068-84.
73. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH. Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 2011; 306: 1549-56.
74. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Systemic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Aliment Pharmacol Ther 2008; 28: 689-703.
75. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, Johnson LL, Gail MH, Dong ZW, Yu B, Mark SD, Taylor PR. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian general population nutrition intervention trial. J Natl Cancer Inst 2009; 101: 507-18.
76. Isaac MG, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2008; (16): CD002854.
77. Blacker D. Mild cognitive impairment - no benefit from vitamin E, little from donepezil. N Engl J Med 2005; 352: 2439-41.
78. Pillai SR, Traber MG, Steiss JE, Kayden HJ, Cox NR. Alpha-tocopherol concentrations of the nervous system and selected tissues of adult dogs fed three levels of vitamin E. Lipids 1993; 28: 1101-5.
79. Vatassery GT, Brin MF, Fahn S, Kayden JH, Traber MG. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats. J Neurochem 1988; 51: 621-3.
80. Halliwell B. Establishing the significance and optimal intake of dietary antioxidants. The biomarker concept. Nutr Rev 1999; 57: 104-13.
81. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A 2008; 105: 11105-9.
82. Clement MV, Ramalingam J, Long LH, Halliwell B. The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antioxid Redox Signal 2001; 3: 157-63.
83. Long LH, Halliwell B. The effects of oxaloacetate on hydrogen peroxide generation from ascorbate and epigallocatechin gallate in cell culture media: potential for altering cell metabolism. Biochem Biophys Res Commun 2012; 417: 446-50.
84. Lehr HA, Vajkoczy P, Menger MD, Arfors KE. Do vitamin E supplements in diets for laboratory animals jeopardize findings in animal models of disease? Free Radic Biol Med 1999; 26: 472-81.
85. Broedbaek K, Ribel-Madsen R, Henriksen T, Weimann A, Petersen M, Andersen JT, Afzal S, Hjelvang B, Roberts LJ II, Vaag A. Genetic and environmental influences on oxidative damage assessed in elderly Danish twins. Free Radic Biol Med 2011; 50: 1488-91.
86. 2-isoprostane levels in humans. Lipids 2005; 40: 329-34.
87. Rao F, Zhang K, Khandrika S, Mahata M, Fung MM, Ziegler MG, Rana BK, O'Connor DT. Isoprostane, an 'intermediate phenotype' for oxidative stress. J Am Coll Cardiol 2010; 56: 1338-50.
88. Wu X, Cai H, Xiang YB, Cai Q, Yang G, Liu D, Sanchez S, Zheng W, Milne G, Shu XO. Intra-person variation of urinary biomarkers of oxidative stress and inflammation. Cancer Epidemiol Biomarkers Prev 2010; 19: 947-52.
89. Block G, Jensen CD, Morrow JD, Holland N, Norkus EP, Milne GL, Hudes M, Dalvi TB, Crawford PB, Fung EB, Schumacher L, Harmatz P. The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 2008; 45: 377-84.
90. Dai Q, Gao YT, Shu XO, Yang G, Milne G, Cai Q, Wen W, Rothman N, Cai H, Li H, Xiang Y, Chow WH, Zheng W. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai women's health study. J Clin Oncol 2009; 27: 2482-8.
91. Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9: 813-39.
92. Belik J, González-Luis GE, Perez-Vizcaino F, Villamor E. Isoprostanes in fetal and neonatal health and disease. Free Radic Biol Med 2011; 48: 177-88.
93. 2-isoprostane level is associated with prostate cancer. J Urol 2011; 185: 2102-7.
94. Epplein M, Franke AA, Cooney RV, Morris JS, Wilkens LR, Goodman MT, Murphy SP, Henderson BE, Kolonel LN, Le Marchand L. Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18: 1962-70.
95. Zipprich J, Terry MB, Liao Y, Agrawal M, Gurvich I, Senie R, Santella RM. Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the breast cancer family registry. Cancer Res 2009; 69: 2966-72.
96. Broedbaek K, Siersma V, Henriksen R, Weimann A, Petersen M, Andersen JT, Jimenez-Solem E, Stovgaard ES, Hansen LJ, Henriksen JE, Bonnema SJ, de Fine Olivarius N, Poulsen HE. Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients. Diabetes Care 2011; 34: 2594-6.
97. Halliwell B, Zhao K, Whiteman ML. The gastrointestinal tract: a major site of antioxidant action? Free Radic Res 2000; 33: 819-30.
98. Gorelik S, Liqumsky M, Kohen R, Kanner J. The stomach as a 'bioreactor': when red meat meets red wine. J Agric Food Chem 2008; 56: 5002-7.
99. Salonen RM, Nyyssönen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen TP, Valkonen VP, Ristonmaa U, Lakka HM, Vanharanta M, Salonen JT, Poulsen HE. Antioxidant Supplementation in Atherosclerosis Prevention Study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the antioxidant supplementation in atherosclerosis prevention (ASAP) study. Circulation 2003; 107: 947-53.
100. Hercberg S, Czernichow S, Galan P. Tell me what your blood beta-carotene level is, I will tell you what your health risk is! The viewpoint of the SUVIMAX researchers. Ann Nutr Metab 2009; 54: 310-2.
101. Mursu J, Robien K, Harnack LJ, Park K, Jacobs JDR. Dietary supplements and mortality rate in older women. Arch Intern Med 2011; 171: 1625-33.
102. Briancon S, Boini S, Bertrais S, Guillemin F, Galan P, Hercberg S. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary preventation SU.VI.MAX trial. Int J Epidemiol 2011; 40: 1605-16.
103. Kesse-Guyot E, Fezeu L, Jeandel C, Ferry M, Andreeva V, Amieva H, Hercberg S, Galan P. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the supplementation in vitamins and mineral antioxidants (SU.VI.MAX) trial. Am J Clin Nutr 2011; 94: 892-9.
104. Kim YS, Young MR, Bobe G, Colburn NH, Milner JA. Bioactive food compounds, inflammatory targets, and cancer prevention. Cancer Prev Res (Phila) 2009; 2: 200-8.
105. Lee CY, Isaac HB, Wang H, Huang SH, Long LH, Jenner AM, Kelly RP, Halliwell B. Cautions in the use of biomarkers of oxidative damage; the vascular and antioxidant effects of dark soy sauce in humans. Biochem Biophys Res Commun 2006; 344: 906-11.
106. Traustadottir T, Davies SS, Stock AA, Su Y, Heward CB, Roberts LJ II, Harman SM. Tart cherry juice decreases oxidative stress in healthy older men and women. J Nutr 2009; 139: 1896-900.
107. Yang X, Croft KD, Lee YP, Mori TA, Puddey IB, Sipsas S, Barden A, Swinny E, Hodgson JM. The effects of a lupin-enriched diet on oxidative stress and factors influencing vascular function in overweight subjects. Antioxid Redox Signal 2010; 13: 1517-24.
108. Lee CY, Isaac HB, Huang SH, Long LH, Wang H, Gruber J, Ong CN, Kelly RP, Halliwell B. Limited antioxidant effect after consumption of a single dose of tomato sauce by young males, despite a rise in plasma lycopene. Free Radic Res 2007; 43: 622-8.
109. Dragsted LO, Pedersen A, Hermetter A, Basu S, Hansen M, Haren GR, Kall M, Breinholt V, Castenmiller JJ, Stagsted J, Jakobsen J, Skibsted L, Rasmussen SE, Loft S, Sandström B. The 6-a-day study: effects of fruit and vegetables on markers of oxidative stress and antioxidative defense in healthy nonsmokers. Am J Clin Nutr 2004; 79: 1060-72.
110. Møller P, Vogel U, Pedersen A, Dragsted LO, Sandström B, Loft S. No effect of 600 grams fruit and vegetables per day on oxidative DNA damage and repair in healthy nonsmokers. Cancer Epidemiol Biomarkers Prev 2003; 12: 1016-22.
111. McAnulty SR, McAnulty LS, Morrow JD, Khardouni D, Shooter L, Monk J, Gross S, Brown V. Effect of daily fruit ingestion on angiotensin converting enzyme activity, blood pressure, and oxidative stress in chronic smokers. Free Radic Res 2005; 39: 1241-8.
112. Crane TE, Kubota C, West JL, Kroggel MA, Wertheim BC, Thomson CA. Increasing the vegetable intake dose is associated with a rise in plasma carotenoids without modifying oxidative stress or inflammation in overweight or obese postmenopausal women. J Nutr 2011; 141: 1827-33.
113. Vissers MN, Zock PL, Leenen R, Roodenburg AJ, van Putte KP, Katan MB. Effect of consumption of phenols from olives and extra virgin oil on LDL oxidizability in healthy humans. Free Radic Res 2001; 35: 619-29.
114. Richelle M, Turini ME, Guidoux R, Tavazzi I, Métairon S, Fay LB. Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett 1999; 459: 259-62.
115. Jackson MJ. Control of reactive oxygen species production in contracting skeletal muscle. Antioxid Redox Signal 2011; 15: 2477-86.